> ## Content Index
> Fetch the complete content index at: https://entrepreneurplus.co.uk/llms.txt
> Use this file to discover other available public pages before exploring further.

# NCL Technology Ventures
- URL: https://entrepreneurplus.co.uk/investors/ncl-technology-ventures/
- Published: 2026-10-15T16:41:35.000Z
- Updated: 2026-10-15T16:41:35.000Z
- Description: London specialist healthcare investor funding early-stage therapeutics, medtech and digital health companies
- Author: Editorial Desk
- Tags: #ep-investor

![NCL Technology Ventures logo](https://storage.ghost.io/c/05/a4/05a4a052-18ab-4836-8924-ec8b322c371c/content/images/2026/10/ncl-technology-ventures-logo.png) 

London specialist healthcare investor funding early-stage therapeutics, medtech and digital health companies

- Venture capital
- London

Type

Venture capital

Based in

London

Stages

Pre-seed, Seed, Series A, Series B+

Sector focus

Fintech, Healthtech

Cheque size

€1.5M–€3M

Fund size

Undisclosed

Founded

2015

Website

[nclim.co.uk](https://nclim.co.uk/?ref=entrepreneurplus.co.uk)

NCL Investment Management, the trading name of NCL Technology Ventures Ltd, is a specialist healthcare investor authorised by the Financial Conduct Authority. It provides equity and operational support to early-stage companies whose technologies aim to prevent, treat or cure disease. Areas of interest include immunology and autoimmune conditions, infectious disease, oncology, women's health and digital health. Its portfolio spans therapeutics and medtech businesses such as TC BioPharm, Centauri Therapeutics, Emteq Labs, Ampersand Health and Curesponse. Managing Partner Jerry Biggs set up the investment management business in 2015\. The firm is headquartered in London, with a satellite office in New Haven, Connecticut.

[LinkedIn](https://www.linkedin.com/company/ncltechnologyventures/?ref=entrepreneurplus.co.uk)

[← All investors](https://entrepreneurplus.co.uk/investors/) · [Is this your organisation? Request an update](https://entrepreneurplus.co.uk/investors/submit/)